Related Experiment Videos
Deep transfer learning for breast cancer detection in underserved regions.
Mahmoud Obaid1, Suhail M Odeh2, Huthaifa I Ashqar3
1Computer System Engineering Department, Arab American University, Jenin, Palestine.
Frontiers in Oncology
|July 13, 2026
Summary
This study introduces a two-step deep learning method for breast cancer detection in mammograms, showing promise for low-resource settings. The AI tool effectively differentiates benign from malignant tumors, aiding diagnostics in underserved regions.
Area of Science:
- Artificial Intelligence in Medical Imaging
- Deep Learning for Cancer Detection
- Health Informatics in Low-Resource Settings
Background:
- Breast cancer is the leading cancer among women in Palestine, contributing to significant mortality.
- The Palestinian healthcare system faces challenges including equipment shortages and limited advanced diagnostics.
- There is a critical need for cost-effective and scalable diagnostic tools in underserved regions.
Purpose of the Study:
- To propose and evaluate a novel two-step deep learning framework for breast cancer detection in mammograms.
- To assess the feasibility of this framework in low-resource environments, specifically Palestine.
- To develop a diagnostic support tool capable of distinguishing between benign and malignant tumors.
Main Methods:
- A U-Net architecture with a VGG16 encoder was utilized for lesion segmentation on the CBIS-DDSM dataset.
- A VGG16 classification model, pre-trained on ImageNet, was employed to classify segmented regions as benign or malignant.
- The framework was evaluated using the CBIS-DDSM dataset for training and validation, and a Palestine Hospital dataset for external testing.
Main Results:
- The U-Net segmentation model achieved a Dice coefficient of 0.74 and a recall of 0.71.
- The VGG16 classifier demonstrated 91% accuracy, 0.95 recall for malignant cases, and an AUC of 0.97 on the Palestine evaluation subset.
- The proposed deep learning approach outperformed ResNet50 (85% accuracy) and MobileNet (82%) in classification tasks.
Conclusions:
- The developed deep learning pipeline is a promising proof-of-concept for breast cancer detection in resource-limited settings.
- The framework's feasibility in low-resource environments suggests potential for scalable and cost-effective diagnostic assistance.
- Further validation on larger, locally annotated datasets is recommended before clinical deployment.